Turning Point Therapeutics, Inc. Human Resources Contracts & Agreements
26 Contracts & Agreements
- Bonus & Incentive Agreements (3 contracts)
- Compensation Agreements (4)
- Consulting Agreements (3)
- Employment Agreements (10)
- Severance Agreements (6)
- Non-Employee Director Compensation Policy, as amended (Filed With SEC on May 10, 2022)
- Executive Employment Agreement, dated March 25, 2022, by and between the Registrant and Brian Sun, M.S., J.D (Filed With SEC on May 10, 2022)
- Transition Consulting Agreement, dated February 16, 2022, by and between the Registrant and Annette North (Filed With SEC on February 28, 2022)
- Turning Point Therapeutics, Inc. Severance Benefit Plan, as amended (C-Suite) November 11, 2021 (Filed With SEC on February 28, 2022)
- Executive Employment Agreement, dated June 22, 2021, by and between the Registrant and Paolo Tombesi (Filed With SEC on August 9, 2021)
- Turning Point Therapeutics, Inc. Severance Benefit Plan, as amended (C-Suite) May 4, 2021 (Filed With SEC on August 9, 2021)
- Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the Turning Point Therapeutics, Inc. 2019 Equity Incentive (Filed With SEC on August 10, 2020)
- Executive Employment Agreement, dated June 26, 2020, by and between the Registrant and Andrew Partridge (Filed With SEC on August 10, 2020)
- Non-Employee Director Compensation Policy as amended June 15, 2020 (Filed With SEC on August 10, 2020)
- Turning Point Therapeutics, Inc. Severance Benefit Plan, as amended (C-Suite) February 15, 2020 (Filed With SEC on March 18, 2020)
- Executive Employment Agreement, dated February 15, 2020, by and between the Registrant and Siegfried Reich, Ph.D (Filed With SEC on March 18, 2020)
- Non-Employee Director Compensation Policy as amended January 06, 2020 (Filed With SEC on March 18, 2020)
- Transition Separation and Consulting Agreement, dated January 9, 2020, by and between Jingrong Jean Cui, Ph.D. and Turning Point Therapeutics, Inc (Filed With SEC on January 9, 2020)
- Executive Employment Agreement, dated October 30, 2019, by and between the Registrant and Mohammad Hirmand, M.D (Filed With SEC on November 4, 2019)
- Turning Point Therapeutics, Inc. Severance Benefit Plan C-Suite, as amended (Filed With SEC on July 29, 2019)
- Executive Employment Agreement, dated July 25, 2019, by and between the Company and Yi Larson (Filed With SEC on July 29, 2019)
- Non-Employee Director Compensation Policy (Filed With SEC on April 8, 2019)
- Executive Employment Agreement, dated March 20, 2019, by and between the Registrant and Annette North (Filed With SEC on April 8, 2019)
- Turning Point Therapeutics, Inc. 2019 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise (Filed With SEC on April 8, 2019)
- Consulting Agreement by and between the Registrant and Sheila K. Gujrathi, M.D. dated as of November 14, 2017 (Filed With SEC on March 21, 2019)
- Executive Employment Agreement, dated September 29, 2018, by and between the Registrant and Yishan (Peter) Li, Ph.D., M.B.A (Filed With SEC on March 21, 2019)
- Amended and Restated Executive Employment Agreement, effective as of January 17, 2019, by and between the Registrant and Jingrong Jean Cui, Ph.D (Filed With SEC on March 21, 2019)
- Executive Employment Agreement, dated September 29, 2018, by and between the Registrant and Athena Countouriotis, M.D (Filed With SEC on March 21, 2019)
- Turning Point Therapeutics, Inc. Severance Benefit Plan (SVP/VP) (Filed With SEC on March 21, 2019)
- Turning Point Therapeutics, Inc. Severance Benefit Plan (C-Suite) (Filed With SEC on March 21, 2019)
- Turning Point Therapeutics, Inc. 2013 Equity Incentive Plan, as amended, and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on March 21, 2019)
